「the 20」の検索結果
144件：61～65件目を表示
-
Publications | Research & Development | SENJU Pharmaceutica
zed, Double-Masked, Dose-Finding Study Yuichi Hori1, Tomoyuki Wada2, Kazunori Omatsu2, on behalf of the SJP-0132 clinical study investigators 1: Department of Ophthalmology, Toho University Faculty of...
http://www.senju.co.jp/english/rd/thesis/ -
ers: Osaka, Japan; President: Mr. Shuhei Yoshida) today announces that it has received approval for the marketing of “Mytear Lumify” (OTC drug requiring instruction by pharmacist, hereinafter this &qu...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903_0.pdf -
研究開発の取り組み | 千寿製薬株式会社
earch and Development System R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licensing★senju.co.jp* When contacting us by e-mail, plea...
http://www.senju.co.jp/english/rd/ -
, Ltd. Launch and Distribution of “MIEr for NAVIS” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution of “MIEr for NAVIS” in Japan. MIEr for NAVIS can sharpen imag...
https://www.senju.co.jp/system/files/content_news/2024-04/ENG_20240423.pdf -
, Ltd. Launch and Distribution of “MIEr for NAVIS” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution of “MIEr for NAVIS” in Japan. MIEr for NAVIS can sharpen imag...
https://www.senju.co.jp/system/files/content_news/2024-04/ENG_20240423_0.pdf